H1 2026
Filed Sep 24, 2026TurboGen Reports First Half 2026 Financial Results and Advances Commercialization Preparations
TurboGen remained pre-revenue and reported higher operating expenses and operating loss, while net loss narrowed due to favorable warrant fair-value and debt-extinguishment effects. Cash increased and the subsequent private placement supports commercialization preparations.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Revenue, six months ended June 30, 2026other | no revenue | – | – |
| Research and development expenses, six months ended June 30, 2026other | $1.9M | – | – |
| Sales and marketing expenses, six months ended June 30, 2026other | $281,000 | – | – |
| General and administrative expenses, six months ended June 30, 2026other | $3.1M | – | – |
| Operating loss, six months ended June 30, 2026other | $5.2M | – | – |
| Net loss, six months ended June 30, 2026other | $4.2M | – | narrowed 45% |
| Cash and cash equivalents, June 30, 2026other | $7.2M | – | – |
| Net cash used in operating activities, six months ended June 30, 2026other | $2.7M | – | – |
| Shareholders’ equity, June 30, 2026other | positive at $1.6 million | – | – |
toward the end of 2026 outlook
- NoteFirst installations of microturbine systems ranging from 32kW to 80kW expected toward the end of 2026.
What drove it
- Research and development expenses reflected increased testing, materials and contractor costs, preparations for scale production, and share-based compensation.
- Sales and marketing expenses primarily reflected higher compensation expenses.
- General and administrative expenses reflected higher share-based compensation and professional expenses associated with the Nasdaq listing.
- Net loss improvement primarily reflected a $6.4 million favorable change in warrant fair-value and debt-extinguishment effects, partially offset by higher operating expenses.
- Completed assembly of the first TR8000 model, an 80kW system designed for large buildings and micro data centers.
Concerns
- TurboGen remained a development-stage company and generated no revenue during this period.
- Operating loss increased to $5.2 million from $2.3 million for the same period last year.
- Net cash used in operating activities was $2.7 million, compared to $1.4 million in the prior-year period.
- The net-loss improvement primarily reflected warrant fair-value and debt-extinguishment effects rather than operating revenue.
What to watch
- First installations of microturbine systems ranging from 32kW to 80kW expected toward the end of 2026.
- Preparations for initial installations and adaptation of systems for scaled production.
- Commercialization progress in the United States and Europe.
- Execution of the Energy-as-a-Service model and installed-system sales with service contracts.
Balance sheet and cash flow
- Cash and cash equivalents totaled $7.2 million on June 30, 2026, compared to $3.9 million on December 31, 2025.
- Net cash used in operating activities was $2.7 million, compared to $1.4 million in the prior-year period.
- Shareholders’ equity was positive at $1.6 million as of June 30, 2026, an improvement of $4.7 million from December 31, 2025.
- Raised $5 million in gross proceeds in an August 2026 private placement.
Analysis
TurboGen remained pre-revenue during the six months ended June 30, 2026, underscoring that the business is still in its development and commercialization-preparation phase. The operating focus was product readiness: the company completed assembly of its first TR8000 model, an 80kW system designed for large buildings and micro data centers, and expects first installations of systems ranging from 32kW to 80kW toward the end of 2026.
Operating investment increased materially. Research and development expenses rose to $1.9 million from $0.6 million, driven by testing, materials, contractor costs, scale-production preparations and share-based compensation. Sales and marketing expenses were $281,000 compared to $203,000, while general and administrative expenses increased to $3.1 million from $1.4 million, including higher share-based compensation and Nasdaq-listing-related professional expenses. These movements accompanied an increase in operating loss to $5.2 million from $2.3 million.
Net loss narrowed 45% to $4.2 million from $7.6 million, but the release attributes the improvement primarily to a $6.4 million favorable change in warrant fair-value and debt-extinguishment effects, partially offset by higher operating expenses. This distinction is important because the company reported no revenue and its underlying operating spending increased. Net cash used in operating activities was also higher at $2.7 million, compared to $1.4 million in the prior-year period.
Liquidity improved at the reporting date, with cash and cash equivalents of $7.2 million on June 30, 2026, compared to $3.9 million on December 31, 2025, and shareholders’ equity positive at $1.6 million. The company subsequently raised $5 million in gross proceeds in an August 2026 private placement. Management frames these resources as support for commercialization, initial installations and scaled-production adaptation, but provided no quantified financial guidance for revenue, margins, expenses or profitability.
Management, verbatim
Our strong cash position of $7.2 million as of June 30, 2026, combined with the $5 million raised in August 2026, supports our preparations for commercialization.
Yaron Gilboa, Chief Executive Officer
Our recent Nasdaq Capital Market (“Nasdaq”) listing is an important milestone that we believe will broaden our visibility among U.S. investors as we advance our commercial strategy.
Yaron Gilboa, Chief Executive Officer
Our priorities are to prepare for initial installations, adapt our systems for scaled production, and advance commercialization in the United States and Europe.
Yaron Gilboa, Chief Executive Officer
Not in the filing
stated, not guessed- Accounting framework, including whether the reported results are under IFRS or another basis.
- Gross profit and gross margin.
- GAAP or adjusted earnings per share.
- Non-GAAP metrics and reconciliations.
- Revenue amount for the comparable six-month period in 2025.
- Segment revenue and segment profitability.
- Debt balances.
- Capital expenditures and free cash flow.
- Dividends or share repurchases.
- Quantified financial guidance for revenue, gross margin, operating expenses, tax rate, profitability, or cash flow.
- Prior outlook for comparison.
AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.